193 related articles for article (PubMed ID: 32529496)
1. Remodelin, an inhibitor of NAT10, could suppress hypoxia-induced or constitutional expression of HIFs in cells.
Wu Y; Cao Y; Liu H; Yao M; Ma N; Zhang B
Mol Cell Biochem; 2020 Sep; 472(1-2):19-31. PubMed ID: 32529496
[TBL] [Abstract][Full Text] [Related]
2. Remodelin, a N-acetyltransferase 10 (NAT10) inhibitor, alters mitochondrial lipid metabolism in cancer cells.
Dalhat MH; Mohammed MRS; Ahmad A; Khan MI; Choudhry H
J Cell Biochem; 2021 Dec; 122(12):1936-1945. PubMed ID: 34605570
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of
Ma N; Liu H; Wu Y; Yao M; Zhang B
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743017
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways.
Rohwer N; Cramer T
Drug Resist Updat; 2011 Jun; 14(3):191-201. PubMed ID: 21466972
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia induced CCR7 expression via HIF-1alpha and HIF-2alpha correlates with migration and invasion in lung cancer cells.
Li Y; Qiu X; Zhang S; Zhang Q; Wang E
Cancer Biol Ther; 2009 Feb; 8(4):322-30. PubMed ID: 19305150
[TBL] [Abstract][Full Text] [Related]
6. Effects of 2-methoxyestradiol on apoptosis and HIF-1α and HIF-2α expression in lung cancer cells under normoxia and hypoxia.
Aquino-Gálvez A; González-Ávila G; Delgado-Tello J; Castillejos-López M; Mendoza-Milla C; Zúñiga J; Checa M; Maldonado-Martínez HA; Trinidad-López A; Cisneros J; Torres-Espíndola LM; Hernández-Jiménez C; Sommer B; Cabello-Gutiérrez C; Gutiérrez-González LH
Oncol Rep; 2016 Jan; 35(1):577-83. PubMed ID: 26548300
[TBL] [Abstract][Full Text] [Related]
7. Ibuprofen-mediated reduction of hypoxia-inducible factors HIF-1alpha and HIF-2alpha in prostate cancer cells.
Palayoor ST; Tofilon PJ; Coleman CN
Clin Cancer Res; 2003 Aug; 9(8):3150-7. PubMed ID: 12912967
[TBL] [Abstract][Full Text] [Related]
8. Current insights and future perspectives of hypoxia-inducible factor-targeted therapy in cancer.
Ajith TA
J Basic Clin Physiol Pharmacol; 2018 Dec; 30(1):11-18. PubMed ID: 30260792
[TBL] [Abstract][Full Text] [Related]
9. Mild chronic hypoxia-induced HIF-2α interacts with c-MYC through competition with HIF-1α to induce hepatocellular carcinoma cell proliferation.
Mu H; Yu G; Li H; Wang M; Cui Y; Zhang T; Song T; Liu C
Cell Oncol (Dordr); 2021 Oct; 44(5):1151-1166. PubMed ID: 34339013
[TBL] [Abstract][Full Text] [Related]
10. Topotecan inhibits vascular endothelial growth factor production and angiogenic activity induced by hypoxia in human neuroblastoma by targeting hypoxia-inducible factor-1alpha and -2alpha.
Puppo M; Battaglia F; Ottaviano C; Delfino S; Ribatti D; Varesio L; Bosco MC
Mol Cancer Ther; 2008 Jul; 7(7):1974-84. PubMed ID: 18645007
[TBL] [Abstract][Full Text] [Related]
11. The hypoxia-associated factor switches cells from HIF-1α- to HIF-2α-dependent signaling promoting stem cell characteristics, aggressive tumor growth and invasion.
Koh MY; Lemos R; Liu X; Powis G
Cancer Res; 2011 Jun; 71(11):4015-27. PubMed ID: 21512133
[TBL] [Abstract][Full Text] [Related]
12. Cobalt stimulates HIF-1-dependent but inhibits HIF-2-dependent gene expression in liver cancer cells.
Befani C; Mylonis I; Gkotinakou IM; Georgoulias P; Hu CJ; Simos G; Liakos P
Int J Biochem Cell Biol; 2013 Nov; 45(11):2359-68. PubMed ID: 23958427
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of pulmonary vascular cell growth by hypoxia-inducible transcription factor-1α and hypoxia-inducible transcription factor-2α.
Ahmad A; Ahmad S; Malcolm KC; Miller SM; Hendry-Hofer T; Schaack JB; White CW
Am J Respir Cell Mol Biol; 2013 Jul; 49(1):78-85. PubMed ID: 23492195
[TBL] [Abstract][Full Text] [Related]
14. Lenticular cytoprotection. Part 1: the role of hypoxia inducible factors-1α and -2α and vascular endothelial growth factor in lens epithelial cell survival in hypoxia.
Neelam S; Brooks MM; Cammarata PR
Mol Vis; 2013; 19():1-15. PubMed ID: 23335846
[TBL] [Abstract][Full Text] [Related]
15. Expression of hypoxia inducible factor 1α and 2α and its association with vitamin C level in thyroid lesions.
Jóźwiak P; Ciesielski P; Zaczek A; Lipińska A; Pomorski L; Wieczorek M; Bryś M; Forma E; Krześlak A
J Biomed Sci; 2017 Oct; 24(1):83. PubMed ID: 29084538
[TBL] [Abstract][Full Text] [Related]
16. Correction to: Remodelin, an inhibitor of NAT10, could suppress hypoxia-induced or constitutional expression of HIFs in cells.
Wu Y; Cao Y; Liu H; Yao M; Ma N; Zhang B
Mol Cell Biochem; 2020 Sep; 472(1-2):33. PubMed ID: 32638257
[TBL] [Abstract][Full Text] [Related]
17. Structural insights of human N-acetyltransferase 10 and identification of its potential novel inhibitors.
Dalhat MH; Altayb HN; Khan MI; Choudhry H
Sci Rep; 2021 Mar; 11(1):6051. PubMed ID: 33723305
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of NAT10 Suppresses Melanogenesis and Melanoma Growth by Attenuating Microphthalmia-Associated Transcription Factor (MITF) Expression.
Oh TI; Lee YM; Lim BO; Lim JH
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28880216
[No Abstract] [Full Text] [Related]
19. Hypoxia and hypoglycaemia in Ewing's sarcoma and osteosarcoma: regulation and phenotypic effects of Hypoxia-Inducible Factor.
Knowles HJ; Schaefer KL; Dirksen U; Athanasou NA
BMC Cancer; 2010 Jul; 10():372. PubMed ID: 20637078
[TBL] [Abstract][Full Text] [Related]
20. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
